• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Advisory Committees

  • Print
  • Share
  • E-mail

March 20, 2014: Vaccines and Related Biological Products Advisory Committee Meeting Draft Roster

Food and Drug Administration
Center for Biologics Evaluation and Research
Vaccines and Related Biological Products Advisory Committee
March 20, 2014


MEMBERS
March 20, 2014

CHAIR
Robert Daum, M.D., C.M.

Expertise:  Molecular Med & Pediatrics
Term:   02/01/2012 – 01/31/2016
Professor of Pediatrics
Microbiology and Molecular Medicine
Director, The University of Chicago MRSA Research Center
Department of Pediatrics, Section of Infectious Diseases
5841 South Maryland Avenue, MC 6054

Chicago, IL  60637
Michael Hudgens, Ph.D.
Expertise:  Biostatistics
Term:   02/01/2012 – 01/31/2016
Associate Professor
Department of Biostatistics
University of North Carolina at Chapel Hill
3107-E McGavran-Greenberg
Chapel Hill, NC  27599
Gillian Air, Ph.D.  ##
Expertise:  Microbiology
Term:  04/25/2011 – 01/31/2015
Vice-chair
Department of Biochemistry & Molecular Biology, BMSB-840
P.O. Box 26901
Oklahoma City, OK  73190
Pedro Piedra, M.D. 
Expertise:  Pediatric Infectious Diseases
Term:  02/01/2012 – 01/31/2016
Professor
Department of Molecular Virology and
Microbiology
Baylor College of Medicine
One Baylor Plaza (MS BCM 280), Rm 248E
Houston, TX  77030
Edgar Marcuse, M.D., M.P.H.
Expertise:  Pediatrics and Epidemiology
Term:  04/25/2011 – 01/31/2015
Associate Medical Director
Seattle Children’s Hospital
4800 Sand Point Way, N.E., T-0111
P.O. Box 5371
Seattle, WA  98105
Stephanie Christner, D.O.  *
Expertise:  Consumer Representative
Term:  07/18/2013 – 01/31/2016
Staff Psychiatrist
MindSpa and Associates
3314 East 46th Street
Tulsa, OK   74135
Janet Englund, M.D.    +
Expertise:  Pediatrics and Infectious Dis
Term:  02/01/2014 – 01/31/2018
Professor
Department of Pediatrics
University of Washington
Director, Pediatric Transplant Infectious Diseases
Seattle Children’s Hospital
4800 Sand Point Way, N.E., #MA7.234
Seattle, WA  98105
Theodore Tsai, M.D.  ** 
Expertise:  Industry Representative
Term:  03/20/2012 – 01/31/2016
Senior Vice President, Scientific Affairs
Novartis Vaccines and Diagnostics
350 Massachusetts Avenue
Cambridge, MA  02139
Karen Kotloff, M.D.
Expertise:  Pediatrics and Infectious Dis.
Term:  02/01/2014 – 01/31/2018
Professor of Pediatrics and Medicine
Head, Division of Infectious Disease and Tropical Pediatrics
Associate Director for Clinical Research
Center for Vaccine Development
University of Maryland School of Medicine
685 W. Baltimore Street
HSF 1, Rm 480
Baltimore, MD  21201
Mark Sawyer, M.D.
Expertise:  Pediatrics and Infectious Dis
Term:   02/01/2014 – 01/31/2018
Professor of Clinical Pediatrics
University of California, San Diego
3020 Children’s Way
San Diego, CA  92123
Sarah Long, M.D.
Expertise:  Pediatrics and Infectious Dis.
Term:  02/01/2014 – 01/31/2018
Professor of Pediatrics
Drexel University College of Medicine
Chief, Section of Infectious Diseases
St. Christopher’s Hospital for Children
Erie Avenue at Front Street
Philadelphia, PA  19134
Acting Designated Federal Officer
Prabhakara Atreya, Ph.D.

DFO, Vaccines and Related Biological Products Advisory Committee
Division of Scientific Advisors and Consultants
Center for Biologics Evaluation & Research
1401 Rockville Pike, HFM-71 Rockville, MD  20852
301-827-0314
fax # 301-827-0294
prabhakara.atreya@fda.hhs.gov
Patrick Moore, M.D., M.P.H.   +
Expertise:  Epidemiology & Micro.
Term:   02/01/2014 – 01/31/2018
American Cancer Society Professor
Distinguished Professor, Microbiology and Molecular Genetics
University of Pittsburgh Cancer Institute
Hillman Cancer Research Pavilion
Suite. 1.8
5117 Centre Avenue
Pittsburgh, PA  15213
Committee Management Specialist
Denise Royster

Division of Scientific Advisors & Consultants
Center for Biologics Evaluation & Research
1401 Rockville Pike, HFM-71
Rockville, MD  20852
301-827-0314
Fax # 301-827-0294
E-mail: denise.royster@fda.hhs.gov
*    Consumer Representative
**  Industry Representative
##  SV Chair, LHV
+ not able to attend

Temporary Voting Member
March 20, 2014
Gary Schoolnik, M.D.  ###
Professor of Medicine and Associate Director
Stanford Institute for Immunology Transplantation and Infectious Diseases
Beckman Center, Room B241A
291 Campus Drive
Stanford, CA  94305
### SV Chair, LRSP

FDA Speakers/Participants
March 20, 2014
Marion Gruber, Ph.D.
Director, OVRR/CBER
Food and Drug Administration
Rockville, MD
Jerry Weir, Ph.D.
Director, Division of Viral Products
OVRR/CBER
Food and Drug Administration
Rockville, MD
Konstantin Chumakov, Ph.D.
Associate Director for Research
OVRR/CBER
Food and Drug Administration
Rockville, MD
Carolyn Wilson, Ph.D.
Associate Director for Research
OVRR/CBER
Food and Drug Administration
Rockville, MD
Marian Major, Ph.D.
Laboratory Chief,
Laboratory of Hepatitis Viruses
Division of Viral Products
OVRR/CBER
Food and Drug Administration
Rockville, MD
Michael Schmitt, Ph.D.
Laboratory Chief
Laboratory of Respiratory and Special Pathogens, Division of Bacterial, Parasitic and Allergenic Products
OVRR/CBER
Food and Drug Administration
Rockville, MD
Jay Slater, M.D.
Director, Division of Bacterial, Parasitic and Allergenic Products, Laboratory of Respiratory and Special Pathogens
OVRR/CBER
Food and Drug Administration
Rockville, MD